// App-Quantinova.ai

420-P : Cystatin C Predicts Major Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with Type 2 Diabetes and in Nondiabetic Individuals

Researchers

Presenter

  • ARTHUR MADER

Principal Investigators

  • Christoph H. Saely

  • Maximilian Maechler

  • BARBARA LARCHER

  • Lukas Sprenger

  • Andreas Leiherer

  • Axel Muendlein

  • Alexander Vonbank

  • Heinz Drexel

Medical Centers

  • N/A

Locations

  • Liechtenstein

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Coronary Artery Disease

  • Chronic kidney disease

  • Type 2 diabetes mellitus

  • Renal disease

  • Diabetes

Biomarkers

  • Cystatin C

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved